In our previous studies, we found and reported that SVEP1, as a promising novel diagnostic and prognostic biomarker, plays various regulatory roles in the malignant progression of hepatocellular carcinoma (Chen et al., 2020; Gong et al., 2022a; Guo et al., 2022). This evidence concerns the gene SVEP1 and hepatocellular carcinoma.